The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 675-682

  Tsuda, H ^a   Yamamoto, K ^a   Inoue, T ^a   Uchiyama, I ^a   Umesaki, N ^b  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CDK; Cyclin D; Endometrial cancer; p16(INK4); pRb

Indexed keywords

CYCLIN D; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; NUCLEAR PROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE DELETION; GENE DOSAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0033967724     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0980     Document Type: Article

References (45)

1. Barbieri F, Cagnoli M, Ragni N, Pedulla F, Foglia G and Alama A (1997) Expression of cyclin D1 correlates with malignancy in human ovarian tumours. Br J Cancer 75: 1263-1268
2. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J (1996) The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56: 5475-5483
3. Buckley M, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA and Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
4. Cairns P, Poladcik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R and Westra W (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11: 210-212
5. Campbell IG, Beynon G, Davis M and Englefield P (1995) LOH and mutation analysis of CDKN2 in primary human ovarian cancer. Int J Cancer 63: 222-225
6. Cirns P et al (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11: 210-212
7. Dutta A, Chandra R, Leiter LM and Lester S (1995) Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 92: 5386-5390
8. Geradts J, Kratzke RA, Crush-Stanton S, Wen SF and Lincoln CE (1996) Wild-type and mutant retinoblastoma protein in paraffin sections. Mod Pathol 9: 339-347
9. Gillett C et al (1996) Cyclin D1 and prognosis in breast cancer. Int J Cancer 69: 92-99
10. Gnozalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA (1995) Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535
11. Hall M and Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68: 67-108
12. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS and James CD (1994) CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res 54: 5804-5807
13. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
14. Hui R, Cornish AL, McClelland RA, Robertson JFR, Blamey RW, Musgrove EA, Nicholson RI and Sutherland RL (1996) Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res 2: 923-928
15. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT and Ally DS (1994) Germline p16 mutations in familial melanoma. Nature Genet 8: 15-21
16. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R and Weinstein IB (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026-9030
17. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocker E, Day RS, III, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
18. Kamb A (1995) Cell-cycle regulators and cancer. Trends Genet 11: 136-140
19. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res 56: 5557-5562
20. INK4A expression in resected non-small cell lung tumors. Cancer Res 56: 3415-3420
21. Li Y, Nicholos MA, Shay JW and Xiong Y (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRB. Cancer Res 54: 6078-6082
22. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ and Horne CHW (1995) Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11: 885-891
23. Maestro R and Boiocchi M (1995) Sunlight and melanoma: an answer from MTS1 (p16). Science 267: 15-16
24. INK4 in human ovarian tumours. Br J Cancer 76: 146-149
25. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squmaous cell carcinomas of the head and neck. Cancer Res 55: 975-978
26. Milde-Langosch K, Riethdorf L, Bamberger AM and Loning T (1999) P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch 434: 23-28
27. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945-2949
28. Nakagawa K, Conrad NK, Williams JP, Johnson BE and Kelly MJ (1995) Mechanism of inactivation of CDKN2 and MTS2 in non-small-cell lung cancer and association with advanced stage. Oncogene 11: 1843-1851
29. Niemann TH, Yilmaz AG, McGaughy VR and Vaccarello L (1997) Retinoblastoma protein expression in endometrial carcinoma. Gynecol Oncol 65: 232-236
30. Peiffer SL, Bartsch D, Whelan AJ, Mutch DG, Herzog TJ and Goodfellow PJ (1995) Low frequency of CDKN2 mutation in endometrial carcinomas. Mol Carcinog 13: 210-212
31. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM and Syrjanen K (1995) Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 31A: 329-333
32. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW and Sutherland RL (1997) Estrogen-induced activation of Cdk4 and Cdk3 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 272: 10882-10894
33. Schauer IE, Siriwardana S, Langan TA and Sclafani RI (1994) Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small and small cell lung cancer. Proc Natl Acad Sci USA 91: 7827-7831
34. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature 366: 704-707
35. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Gene Dev 9: 1149-1163
36. Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV and O'Brien TJ. (1997) p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Invest 4: 95-102
37. INK4 in human endometrioid-type endometrial carcinoma. Cancer 80: 2250-2256
38. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630
39. Strauss M, Lukas J and Bartek J (1995) Unrestricted cell cycling and cancer. Nat Med 1: 1245-1246
40. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond) 369: 669-671
41. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
42. Yao J, Pollock RE, Lang A, Ming T, Pisters PWT, Goodrich D, El-Naggar A and Yu Dihua (1998) Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Clin Cancer Res 4: 1065-1070
43. Yaginuma Y, Katayama H, Kawai K, Duenas JC and Ishikawa M (1996) Analysis of the retinoblastoma gene in human endometrial carcinoma. Obstet Gynecol 87: 755-759
44. Zhang T, Nanney LB, Luongo C, Lamps, Heppner KJ, DuBois RN and Beauchamp RD (1997) Concurrent overexpression of cyclinD1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res 51: 169-175
45. Zuberberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV and Arnold A (1995) Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8: 560-566